| Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System (NCT04079114) | Zimmer Biomet | 2011-04-28 |
| Difference in GC-induced Adrenal Insufficiency in RA Related to Polymorphisms in the Glucocorticoid Receptor Gene (NCT01411046) | Rigshospitalet, Denmark | 2011-04-01 |
| Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects. (NCT01336218) | AstraZeneca | 2011-04-01 |
| Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069 (NCT01346501) | AbbVie (prior sponsor, Abbott) | 2011-04-01 |
| Safety Study of Abatacept in Sweden (NCT01094795) | Bristol-Myers Squibb | 2011-03-31 |
| Tocilizumab Effect on microRNA Expression and Adipokine Levels in Rheumatoid Arthritis Patients (NCT03149796) | Carmel Medical Center | 2011-03-23 |
| Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056 (NCT01296711) | UCB BIOSCIENCES, Inc. | 2011-03-07 |
| Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects (NCT01309854) | AstraZeneca | 2011-03-01 |
| Effects of Denosumab on the Pharmacokinetics of Etanercept (NCT01294397) | Amgen | 2011-03-01 |
| Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis (NCT01299961) | University of California, Los Angeles | 2011-03-01 |
| A Study of RoActemra/Actemra and, if Initially Inadequately Responded to RoActemra/Actemra, Followed by MabThera/Rituxan in Patients With Rheumatoid Arthritis (NCT01332994) | Hoffmann-La Roche | 2011-03-01 |
| Joint Ultrasound Evaluation of Asymptomatic Rheumatic Feet (NCT01677416) | Federal University of São Paulo | 2011-03-01 |
| Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage (NCT01333878) | Orrin M Troum, M.D. and Medical Associates | 2011-03-01 |
| Exercise-induced Improvements of Inflammatory Status in Patients With Rheumatoid Arthritis (NCT01478334) | Norwegian University of Science and Technology | 2011-03-01 |
| Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients (NCT01284569) | Ablynx, a Sanofi company | 2011-03-01 |
| A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis (NCT01317797) | Takeda | 2011-03-01 |
| Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis (NCT01301703) | Tel-Aviv Sourasky Medical Center | 2011-03-01 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs (NCT01353859) | Hoffmann-La Roche | 2011-03-01 |
| Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel) (NCT01313208) | Amgen | 2011-03-01 |
| Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects (NCT01311622) | AstraZeneca | 2011-03-01 |
| A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT01232569) | Hoffmann-La Roche | 2011-03-01 |
| An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) (NCT01392001) | Hoffmann-La Roche | 2011-03-01 |
| Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA Trial (NCT01315652) | Assistance Publique - Hôpitaux de Paris | 2011-03-01 |
| Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab (NCT01282372) | AbbVie (prior sponsor, Abbott) | 2011-03-01 |
| Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease (NCT01566201) | University of Athens | 2011-03-01 |
| Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions (NCT01305356) | BioMimetic Therapeutics | 2011-03-01 |
| Database Retrieval for the Comprehensive Shoulder (NCT03409718) | Zimmer Biomet | 2011-02-24 |
| Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants (NCT01064063) | Zimmer Biomet | 2011-02-15 |
| A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA) (NCT01285752) | Asahi Kasei Therapeutics Corporation | 2011-02-01 |
| Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy (NCT01299545) | TcLand Expression S.A. | 2011-02-01 |
| Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis (NCT01765374) | University Hospital, Rouen | 2011-02-01 |
| A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept (NCT01339481) | Astellas Pharma Inc | 2011-02-01 |
| Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study (NCT02092961) | AstraZeneca | 2011-02-01 |
| Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis (NCT01282255) | Novo Nordisk A/S | 2011-02-01 |
| An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment (NCT01254331) | Hoffmann-La Roche | 2011-02-01 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER) (NCT01235507) | Hoffmann-La Roche | 2011-02-01 |
| A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA) (NCT01292265) | UCB Pharma | 2011-02-01 |
| PMCF Study of the CLS Brevius Stem With Kinectiv Technology (NCT03410940) | Zimmer Biomet | 2011-01-07 |
| A Rheumatoid Arthritis Study in Participants (NCT01202760) | Eli Lilly and Company | 2011-01-01 |
| Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) (NCT01242514) | AstraZeneca | 2011-01-01 |
| A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE) (NCT01219933) | Hoffmann-La Roche | 2011-01-01 |
| Acetabular Shell Positioning Using Patient Specific Instruments (NCT01791738) | The Cleveland Clinic | 2011-01-01 |
| Effect of Fish Oil on Surgery Pain After Knee Replacement Patients: Randomized, Prospective, Double Blind, Placebo Control Trial (NCT01274910) | Rabin Medical Center | 2011-01-01 |
| Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate (NCT01270035) | Keio University | 2011-01-01 |
| An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE) (NCT01384461) | Hoffmann-La Roche | 2011-01-01 |
| Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA) (NCT01264770) | AstraZeneca | 2011-01-01 |
| GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy (NCT01274182) | Sandoz | 2011-01-01 |
| Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab (NCT01273519) | AbbVie (prior sponsor, Abbott) | 2011-01-01 |
| A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department (NCT01411215) | Pfizer | 2011-01-01 |
| Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA) (NCT01382160) | University Hospital, Tours | 2011-01-01 |
| A Study in Participants With Rheumatoid Arthritis (NCT01202773) | Eli Lilly and Company | 2011-01-01 |
| A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis (NCT01223911) | Novo Nordisk A/S | 2011-01-01 |
| Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration (NCT01737944) | Antares Pharma Inc. | 2011-01-01 |
| Safety Study of Abatacept to Treat Rheumatoid Arthritis (NCT01247766) | Bristol-Myers Squibb | 2010-12-31 |
| An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct) (NCT01483326) | Hoffmann-La Roche | 2010-12-31 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients (NCT02675803) | Novartis Pharmaceuticals | 2010-12-20 |
| Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis (NCT01285310) | Amgen | 2010-12-09 |
| Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA) (NCT01235598) | UCB Pharma | 2010-12-01 |
| Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis (NCT01142726) | Bristol-Myers Squibb | 2010-12-01 |
| Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients (NCT01270997) | Hanwha Chemical | 2010-12-01 |
| A Study of LY2439821 in Rheumatoid Arthritis (NCT01236118) | Eli Lilly and Company | 2010-12-01 |
| Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX) (NCT01481493) | Biotest | 2010-12-01 |
| Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis (NCT01261403) | Celularity Incorporated | 2010-12-01 |
| A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate (NCT01198002) | Eli Lilly and Company | 2010-12-01 |
| Study to Assess Safety, Tolerability, and Pharmacokinetics of Oral Doses for AC430 in Healthy Subjects (NCT01287858) | Daiichi Sankyo | 2010-11-01 |
| A Study of Fostamatinib in Subjects With Impaired Kidney Function (NCT01245790) | AstraZeneca | 2010-11-01 |
| Chronic Periodontitis and Tooth Loss in Patients With Rheumatoid Arthritis (NCT02441920) | University of Birmingham | 2010-11-01 |
| Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers (NCT01217814) | Sanofi | 2010-11-01 |
| Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy (NCT01242488) | UCB Pharma | 2010-11-01 |
| Quality of Life in Chronic Arthritis (NCT01357018) | Far Eastern Memorial Hospital | 2010-11-01 |
| N-3 PUFA and Rheumatoid Arthritis in Korea (NCT01618019) | Hanyang University | 2010-11-01 |
| Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy (NCT01521884) | Pfizer | 2010-11-01 |
| Therapeutic Management of Periodontitis and Clinical Manifestations of Rheumatoid Arthritis (NCT02779179) | University Hospital, Toulouse | 2010-11-01 |
| Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis (NCT01225991) | University of California, Los Angeles | 2010-11-01 |
| A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects (NCT01255761) | UCB Pharma | 2010-11-01 |
| Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy (NCT01362062) | Hoffmann-La Roche | 2010-10-26 |
| Multi Centre Study on TESS V2 Shoulder System (NCT03431857) | Zimmer Biomet | 2010-10-20 |
| INBONE Total Ankle Arthroplasty(TAA)Using Calcaneal Stem Fixation (NCT01366989) | Stryker Trauma and Extremities | 2010-10-01 |
| Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA) (NCT01098201) | University of Rochester | 2010-10-01 |
| Safety and Efficacy of the Combination of Diacerein 100 mg Daily and MTX Versus MTX Alone in the Treatment of Early Rheumatoid Arthritis (RA) (NCT01264211) | TRB Chemedica | 2010-10-01 |
| Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA) (NCT01217086) | Celltrion | 2010-10-01 |
| Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis (NCT02528292) | Barts & The London NHS Trust | 2010-10-01 |
| GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis (NCT01211249) | Lakefront Biotherapeutics NV | 2010-10-01 |
| A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis (NCT01214733) | Hoffmann-La Roche | 2010-10-01 |
| Correlation Between Beliefs About Medicine and Objective Measures of Efficacy and Safety in Rheumatoid Arthritis (RA) (NCT01432366) | Pfizer | 2010-10-01 |
| Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept (NCT01221636) | Bristol-Myers Squibb | 2010-10-01 |
| Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis (NCT01034306) | Can-Fite BioPharma | 2010-10-01 |
| Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA) (NCT01164579) | Pfizer | 2010-10-01 |
| A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDS (NCT01149057) | Hoffmann-La Roche | 2010-10-01 |
| Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy (NCT01248780) | Centocor, Inc. | 2010-09-01 |
| A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA) (NCT01116141) | Chelsea Therapeutics | 2010-09-01 |
| A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy (NCT01242917) | Amgen | 2010-09-01 |
| Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial (NCT01205854) | Espen A. Haavardsholm | 2010-09-01 |
| First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis (NCT01208506) | Novo Nordisk A/S | 2010-09-01 |
| Improving Bone Health Among Rheumatoid Arthritis (RA) Patients on Chronic Glucocorticoids (NCT01378689) | University of Alabama at Birmingham | 2010-09-01 |
| A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) (NCT01185288) | AbbVie (prior sponsor, Abbott) | 2010-09-01 |
| The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients (NCT01213017) | Oklahoma Medical Research Foundation | 2010-09-01 |
| A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RA (NCT01078597) | AbbVie (prior sponsor, Abbott) | 2010-09-01 |
| A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects (NCT01184001) | Pfizer | 2010-09-01 |
| Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding. (NCT01197521) | AstraZeneca | 2010-09-01 |